Home / Publication / Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%

論文

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%

Author(s): Eleftheria Tsakalozou, Andrew Babiskin, LiangZhao

Year: 2020年12月29日

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%

Accelerated ADC Approval Through Expert Modeling and Data Rescue

Merck Advances Pediatric Oncology with Innovative ADC Modeling

ICoP 2026 India

Virtual Triplets: The Next Step in Personalized and Ethical Drug Development

メルマガ登録

クイックアクセス

ソリューション

お問合せ